PCRX 8-K 2026-11-05

Pacira BioSciences, Inc. (PCRX) 8-K dated 2026-11-05 — accession 0001628280-26-071129.

Pacira BioSciences, Inc. (PCRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.

Pacira BioSciences, Inc. filed a 8-K on 2026-11-05. Accession 0001628280-26-071129.

This 8-K covers: Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported PCRX revenue for 2025-12-31 was $726.4M. Net income was $7.0M. Revenue was up 3.6% from 2024-12-31 to 2025-12-31. PCRX currently screens at market cap $890.8M.

Not investment advice. The PCRX SEC hub lists recent forms. The stock page is the research view.